US76243J1051
US76243J1051
Rhythm Pharmaceuticals, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 6.23B EUR | 7.64B EUR | 5.95B EUR | 7.19B EUR |
Enterprise Value | 6.07B EUR | 7.58B EUR | 5.89B EUR | 7.14B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -171.79x | -- | -- | -- |
Price to Sales | 25.95x | 31.85x | 27.41x | 45.8x |
Price to Book | 60.68x | 35.16x | 25.05x | 26.64x |
EV/Revenue | 25.28x | 31.59x | 27.14x | 45.48x |
EV/EBITDA | -30.39x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -2.1% | -1.39% | -2.02% | -1.06% |